Trxade Group logo
Trxade Group MEDS

Annual report 2025
added 03-30-2026

report update icon

Trxade Group Cash and Cash Equivalents 2011-2026 | MEDS

Annual Cash and Cash Equivalents Trxade Group

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.66 M - 152 K 1.09 M 3.12 M 5.92 M 2.87 M 870 K 184 K 14.7 K 78.7 K 706 K 84.3 K - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.66 M 14.7 K 1.81 M

Quarterly Cash and Cash Equivalents Trxade Group

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
356 K 15.4 K 2.05 M 308 K 579 K 7.72 M - 314 34 K 746 K 1.19 M 1.09 M 322 K - 1.87 M 3.12 M 3.57 M 4.52 M 5.21 M 5.92 M 5.92 M 5.92 M 5.92 M 2.87 M 2.87 M 2.87 M 2.87 M 870 K 870 K 870 K 190 K 184 K 173 K 184 K 184 K 14.7 K 14.7 K 14.7 K 14.7 K 78.7 K 860 K 860 K 860 K 696 K 271 K 70.5 K 706 K 84.3 K 84.3 K 84.3 K - 3.38 K - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
7.72 M 314 1.55 M

Cash and Cash Equivalents of other stocks in the Pharmaceutical retailers industry

Issuer Cash and Cash Equivalents Price % 24h Market Cap Country
BOQI International Medical BOQI International Medical
BIMI
2.34 M - 6.33 % $ 5.86 M chinaChina
Greenlane Holdings Greenlane Holdings
GNLN
32.5 M $ 2.93 1.74 % $ 22 M usaUSA
PetMed Express PetMed Express
PETS
54.7 M $ 2.3 -0.43 % $ 47.4 M usaUSA
Rite Aid Corporation Rite Aid Corporation
RAD
157 M - - $ 35.5 M usaUSA
Walgreens Boots Alliance Walgreens Boots Alliance
WBA
1.32 B - - $ 10.3 B usaUSA
111 111
YI
1.19 B $ 6.58 2.65 % $ 1.13 B chinaChina
LifeMD LifeMD
LFMD
36.8 M - - $ 157 M usaUSA